Amgen Inc. (NASDAQ:AMGN) plans to lay off 70 workers at its Thousand Oaks headquarters, mostly in information technology jobs. The pharmaceutical company announced the cuts in an email, specifying that the positions are predominantly in the information systems department with a small number elsewhere. Amgen, Inc. (NASDAQ:AMGN) net profit margin is 24.90% and weekly performance is 1.58%. On last trading day company shares ended up $117.82. Analysts mean target price for the company is $132.78. Amgen, Inc. (NASDAQ:AMGN) distance from 50-day simple moving average (SMA50) is 2.34%.
Teva Pharmaceutical Industries Ltd (NASDAQ:TEVA) was upgraded by research analysts at Argus from a “hold” rating to a “buy” rating in a report released on Friday, TheFlyOnTheWall.com reports. The firm currently has a $58.00 price target on the stock. Argus’ target price suggests a potential upside of 13.84% from the stock’s previous close. Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) shares advanced 0.26% in last trading session and ended the day on $51.08. TEVA gross Margin is 53.00% and its return on assets is 2.90%.Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) quarterly performance is 4.33%.
Merck & Co., Inc. (NYSE:MRK), health care company is engaged in providing medical solutions as medicines, vaccines and biologic therapies. Merck & Co. has recently announced that its new immunotherapy has produced positive results in patients suffering from advanced melanoma. Merck & Co., Inc. (NYSE:MRK) shares moved down -0.43% in last trading session and was closed at $57.85, while trading in range of $57.68 – $58.26. Merck & Co., Inc. (NYSE:MRK) year to date (YTD) performance is 16.49%.
A Maryland judge on Monday freed Pfizer Inc. (NYSE:PFE) from a personal injury suit blaming insulation manufactured by its defunct subsidiary Quigley Co. for a deceased bricklayer’s mesothelioma, marking Pfizer’s third straight victory among asbestos cases that got the go-ahead last year to circumvent Quigley’s bankruptcy shield. Pfizer Inc. (NYSE:PFE) ended the last trading day at $29.42. Company weekly volatility is calculated as 1.05% and price to cash ratio as 5.53.Pfizer Inc. (NYSE:PFE) showed a negative weekly performance of -0.71%.
Takeda Pharmaceutical Co Ltd (ADR) (OTCMKTS:TKPYY) and subsidiary Takeda Pharmaceuticals International GmbH on 29 may announced that the companies have received Marketing Authorization from the European Commission for Entyvio (vedolizumab) for ulcerative colitis (UC) and Crohn’s disease (CD) in the EU. On last trading day company shares ended up $23.14.